Connor, Clark & Lunn Investment Management (CC&L)’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-129,026
Closed -$188K 1531
2025
Q1
$188K Sell
129,026
-188,474
-59% -$368K ﹤0.01% 1333
2024
Q4
$486K Buy
317,500
+43,165
+16% +$70.2K ﹤0.01% 1151
2024
Q3
$497K Buy
274,335
+124,190
+83% +$227K ﹤0.01% 1102
2024
Q2
$252K Buy
150,145
+12,836
+9% +$26.7K ﹤0.01% 1224
2024
Q1
$354K Buy
+137,309
New +$320K ﹤0.01% 1211

Other funds holding CGEN

Connor, Clark & Lunn Investment Management (CC&L)'s CGEN Position: Q2 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Compugen (CGEN) in Q2 2025, closing a stake of 129,026 shares — an estimated $188K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CGEN in Q1 2024 and held it in 5 quarters. The position peaked at $497K in Q3 2024. 70 funds tracked by Wall St. Rank hold CGEN as of Q2 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Compugen position as of Q2 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 129,026 Compugen shares in Q2 2025, an estimated $188K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Compugen in Q1 2024 and held it in 5 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Compugen position peaked at $497K in Q3 2024.
  • 70 funds tracked by Wall St. Rank held Compugen as of Q2 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2025, filed 7 Aug 2025.